BioAge Labs sells 588,888 shares to Sofinnova at $18 in private placement concurrent with IPO

BioAge Labs, Inc.

Private placement of 588,888 shares to existing stockholder Sofinnova at IPO price of $18.00/share, raising $10.6 million.
Placement agents Goldman Sachs, Morgan Stanley, Jefferies, Citigroup received 7.0% fee on total purchase price.
Shares unregistered, issued under Section 4(a)(2) to an institutional accredited investor; registration rights after one year if not saleable under Rule 144.
Closing occurred on September 27, 2024, concurrently with the IPO closing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.